New Drug Approved for Peripheral T-Cell Lymphoma — Physician’s First Watch
July 7, 2014
New Drug Approved for Peripheral T-Cell Lymphoma
By the Editors
The FDA has approved belinostat (Beleodaq) to treat relapsed or refractory peripheral T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The drug stops enzymes that contribute to T-cells turning cancerous.